SAN FRANCISCO   â€”    Innate Immunotherapeutics is a tiny pharmaceutical company from Australia that has no approved drugs and no backing from flashy venture capital firms , and trades for just over a dollar a share on the Australian Stock Exchange .More than once , Innate Immunotherapeutics has run out of money and nearly closed its Innate Immunotherapeutics .But despite its Innate Immunotherapeutics profile , Innate has some surprisingly influential boosters in Washington .